Everolimus and PTK/ZK show synergistic growth inhibition in the orthotopic BL16/BL6 murine melanoma model. [electronic resource]
Producer: 20110131Description: 193-200 p. digitalISSN:- 1432-0843
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Drug Synergism
- Everolimus
- Female
- Mechanistic Target of Rapamycin Complex 1
- Melanoma, Experimental -- drug therapy
- Mice
- Mice, Inbred C57BL
- Models, Biological
- Multiprotein Complexes
- Neoplasm Metastasis
- Phthalazines -- administration & dosage
- Proteins -- antagonists & inhibitors
- Pyridines -- administration & dosage
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Sirolimus -- administration & dosage
- TOR Serine-Threonine Kinases
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.